EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The sampling bottleneck in antimicrobial susceptibility testing: consequences and paths forward

Ivan Brukner iD, Mathew Oughton

Journal of Clinical Microbiology · 13.05.2026 · 64 (5)

DOI: 10.1128/jcm.01788-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Microbiology, erschienen am 13.05.2026. Verfasst von Ivan Brukner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Laboratory, Jewish General Hospital, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional antimicrobial susceptibility testing (AST) is based on inocula derived from a small number of colonies, creating a substantial sampling bottleneck relative to the complexity of within-host bacterial populations. Although this limitation is well recognized, its clinical impact is likely limited in many immunocompetent hosts, where effective immune responses and adequate antimicrobial exposure buffer against the influence of low-frequency resistant subpopulations. However, genomic and mechanistic studies show that such subpopulations can exist at low frequencies and may become clinically relevant in high-risk settings, including persistent or high-burden infections and in profoundly immunocompromised patients. This article outlines the biological basis of the sampling constraint, clarifies when it is most likely to matter, and discusses targeted population-based and sequencing-informed adjunct approaches that may complement reference AST in select scenarios. Improving transparency around these limitations—without undermining confidence in standardized methods—supports antimicrobial stewardship and more nuanced interpretation in defined clinical contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacteriaHumansMicrobial Sensitivity TestsDrug Resistance, BacterialBacterial InfectionsImmunocompromised Host

Stichwörter der Autor:innen

antimicrobial susceptibility testingfew-colony inoculum population analysis minority-resistant subpopulations CLSI/…heteroresistanceimmunocompromised hosttherapeutic failure

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Microbiology Laboratory, Jewish General Hospital, Montréal, Québec, Canada.
  • Department of Medicine, McGill University, Montréal, Québec, Canada.

ORCID-Profile: Ivan Brukner

Zitieren

APA

Brukner, I., & Oughton, M. (2026). The sampling bottleneck in antimicrobial susceptibility testing: consequences and paths forward. Journal of Clinical Microbiology, 64(5). https://doi.org/10.1128/jcm.01788-25

Vancouver

Brukner I, Oughton M. The sampling bottleneck in antimicrobial susceptibility testing: consequences and paths forward. Journal of Clinical Microbiology. 2026;64(5). doi:10.1128/jcm.01788-25

BibTeX
@article{Brukner2026,
  author = {Brukner, Ivan and Oughton, Mathew},
  title = {The sampling bottleneck in antimicrobial susceptibility testing: consequences and paths forward},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  volume = {64},
  number = {5},
  doi = {10.1128/jcm.01788-25}
}
Kostenlos starten →